Doctor profile · Federal record
Dr. Thomas Blevins, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Austin, TX
- NPI 1114992088
- Accepts Medicare
- MIPS 83.4 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6500 North Mo PAC Expressway, Building 3, Suite 200
Austin, TX 78731
(512) 458-8400
fax (512) 458-8593
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- January 6, 2011
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Texas #F9214
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114992088. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,995
Distinct HCPCS
5
Medicare allowed
$215,921
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,492 | 836 | $129 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 302 | 145 | $34 | |
96372 |
Injection of drug or substance under skin or into muscle | 108 | 22 | $14 | |
76536 |
Ultrasound scan of head and neck soft tissue | 82 | 80 | $117 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 11 | 11 | $222 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 400. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$107,038
Transactions
164
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 30 | $44,184.36 | |
| Lilly USA, LLC | 58 | $29,689.40 | |
| Dexcom, Inc. | 14 | $13,938.92 | |
| Novo Nordisk Inc | 17 | $6,568.86 | |
| Medtronic, Inc. | 12 | $3,542.41 | |
| Mannkind Corporation | 11 | $2,878.70 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $2,275.76 | |
| Insulet Corporation | 4 | $2,000.00 | |
| ConvaTec Inc. | 1 | $1,450.00 | |
| AstraZeneca Pharmaceuticals LP | 2 | $119.30 | |
| ABBVIE INC. | 3 | $76.93 | |
| Amgen Inc. | 4 | $59.41 | |
| Antares Pharma, Inc. | 2 | $36.86 | |
| BETA BIONICS, INC. | 1 | $34.89 | |
| Genentech, Inc. | 1 | $32.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
6,540
Patients
1,962
Total drug cost
$1,735,728
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 1,363 | 390 | $22,978 |
| Rosuvastatin Calcium | Generic | 733 | 223 | $12,722 |
| Synthroid (Levothyroxine Sodium) | Brand | 728 | 193 | $74,723 |
| Ezetimibe | Generic | 701 | 230 | $26,789 |
| Atorvastatin Calcium | Generic | 654 | 211 | $8,413 |
| Alendronate Sodium | Generic | 413 | 140 | $5,166 |
| Ozempic (Semaglutide) | Brand | 320 | 84 | $534,853 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 314 | 101 | $4,841 |
| Trulicity (Dulaglutide) | Brand | 311 | 79 | $556,654 |
| Jardiance (Empagliflozin) | Brand | 228 | 65 | $304,113 |
Frequently asked questions
What is Dr. Thomas Blevins's medical specialty?
Dr. Thomas Blevins practices Endocrinology, Diabetes & Metabolism Physician in Austin, TX.
Where does Dr. Thomas Blevins practice?
Dr. Thomas Blevins practices at 6500 North Mo PAC Expressway, Austin, TX 78731. Office phone: 5124588400.
What is Dr. Thomas Blevins's NPI?
Dr. Thomas Blevins's National Provider Identifier (NPI) is 1114992088, issued by NPPES.
Does Dr. Thomas Blevins accept Medicare assignment?
Yes. Dr. Thomas Blevins accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Thomas Blevins commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Injection of drug or substance under skin or into muscle (HCPCS 96372). Source: CMS Medicare Physician & Other Practitioners file.